Technologies

Antitope’s core proprietary technologies are as follows:

• 

  EpiScreen™, an ex vivo human T cell assay technology for predicting the immunogenicity of biologics or for identifying T cell epitopes within the sequences of biologics.

• 

  Composite Human Antibody™ technology, for generating humanized antibodies devoid of human T cell epitopes.

• 

  Composite Protein™ technology, for generating therapeutic proteins devoid of human T cell epitopes.